SpiderRock Advisors LLC Has $548,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

SpiderRock Advisors LLC cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 61,104 shares of the pharmacy operator’s stock after selling 1,730 shares during the period. SpiderRock Advisors LLC’s holdings in Walgreens Boots Alliance were worth $548,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in WBA. CWA Asset Management Group LLC acquired a new position in Walgreens Boots Alliance during the third quarter valued at approximately $106,000. Philip James Wealth Mangement LLC bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at $5,252,000. Keudell Morrison Wealth Management acquired a new stake in Walgreens Boots Alliance during the 3rd quarter worth $107,000. Deseret Mutual Benefit Administrators lifted its holdings in Walgreens Boots Alliance by 14.1% during the third quarter. Deseret Mutual Benefit Administrators now owns 16,268 shares of the pharmacy operator’s stock worth $146,000 after acquiring an additional 2,010 shares in the last quarter. Finally, Principal Financial Group Inc. grew its stake in Walgreens Boots Alliance by 2.9% in the third quarter. Principal Financial Group Inc. now owns 886,144 shares of the pharmacy operator’s stock valued at $7,940,000 after acquiring an additional 24,974 shares during the period. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $9.39 on Tuesday. The company has a market cap of $8.12 billion, a PE ratio of -0.94, a price-to-earnings-growth ratio of 1.19 and a beta of 0.69. The firm has a 50-day moving average of $9.18 and a 200-day moving average of $12.13. Walgreens Boots Alliance, Inc. has a one year low of $8.22 and a one year high of $27.05. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter in the previous year, the business earned $0.67 earnings per share. The business’s revenue was up 5.9% compared to the same quarter last year. As a group, equities analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 10.65%. The ex-dividend date is Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is -9.99%.

Analysts Set New Price Targets

Several brokerages recently issued reports on WBA. Evercore ISI boosted their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. UBS Group increased their price objective on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, October 17th. Truist Financial reduced their target price on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, August 30th. Finally, Barclays upped their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.